Stock Information
Rhythm Pharmaceuticals Inc (RYTM)
Ticker Symbol: RYTM
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $5,758.65 mil
Piotroski score: 6
PE Ratio: N/A
EPS (TTM): -3.0256
Revenue (TTM): $2.84 M
Dividend Yield: N/A%
ROE: -91.16%
Latest News
-
Rhythmn Pharmaceuticals Announces European Commission Expansion Of The Marketing Authorization For Imcivree For Obesity And Control Of Hunger In Adults And Children 4 Years Of Age And Above With Acquired Hypothalamic Obesity
Fri, May 1, 2026 6:58 AM
-
Rhythm Pharmaceuticals Announces IMCIVREE® (Setmelanotide) Granted Marketing Authorization by European Commission for the Treatment of Obesity and Control of Hunger in Patients with Acquired Hypothalamic Obesity
Fri, May 1, 2026 6:55 AM
Key Financials
Financial data not available
